Peiqing Liu

Biography

Peiqing Liu, Director and Professor in Laboratory of Pharmacology & Toxicology, School of Pharmaceutical Science, Sun Yat-Sen University (SYSU). Until now, he has worked in the field of cardiovascular pharmacology and molecular biology for over 20 years, particularly in signal transduction, interaction between transcriptional factors and proteomic analysis in myocardial hypertrophy. He has published more than 130 research articles among which over 70 entered SCI, EI, ISTP, and is co-writer of 5 published monographs. As the director of New Drug R&D Center, he has established an advanced new drug evaluation and screening system and constructed a serial of new drug targets. His work was recognized by the SYSU and government, and two laboratories under his leadership, Guangdong Provincial Engineering Laboratory of Druggability Assessment and Evaluation, and Guangzhou Key Laboratory of Druggability Assessment for Biologically Active Compounds have been approved by Guangdong Province and Guangzhou City government. His research programs are supported by National Natural Science Foundation of China (NSFC), the National Science and Technology Major Project of China “Key New Drug Creation and Manufacturing Program”, Team Item of Natural Science Foundation of Guangdong Province, etc. Recently, He has also completed a new drug’s R&D for the treatment of Alzheimer’s disease in response to a program launched by the Ministry of Health of China.

Research Interest

Advanced new drug evaluation